Co-Diagnostics, Inc. Operating Income Loss

• Co-Diagnostics, Inc. showed a decrease of -25.2% in Operating Income Loss from 2024 to 2025.
• This data is from Co-Diagnostics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Co-Diagnostics, Inc.'s Operating Income Loss has declined by 2,871.9%.
• Historical annual values: Fiscal year 2025: -$50.17 million | Fiscal year 2024: -$40.08 million | Fiscal year 2023: -$42.71 million | Fiscal year 2022: -$26.98 million | Fiscal year 2021: $46.06 million | Fiscal year 2020: $41.69 million | Fiscal year 2019: -$5.89 million | Fiscal year 2018: -$6.12 million | Fiscal year 2017: -$4.56 million | Fiscal year 2016: -$1.69 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026